Maggie O’Neill is a health writer and reporter based in New York who specializes in covering medical research and emerging wellness trends, with a focus on cancer and addiction. Prior to her time at Health, her work appeared in the Observer, Good Housekeeping, CNN, and Vice. She was a fellow of the Association of Health Care Journalists’ 2020 class on Women’s Health Journalism and 2021 class on Cancer Reporting. In her spare time, she likes meditating, watching TikToks, and playing fetch with her dog, Finnegan., More than half of Americans qualify for GLP-1 receptor agonist drugs, but many can't afford them. Experts share cheaper options to access GLP-1s—and warn of their potential risks., Wegovy injection is approved to aid adults and adolescents aged 12 years and older dealing with obesity, or adults with excessive weight (overweight) accompanied by weight-related medical conditions. Novo Nordisk manufactures all three medications, which are only accessible with a prescription, and currently, no approved generic alternatives .